{"gene":"TWIST2","run_date":"2026-06-10T10:51:56","timeline":{"discoveries":[{"year":1995,"finding":"Dermo-1 (TWIST2) is a bHLH protein that dimerizes with the ubiquitous bHLH protein E12 to bind E-box consensus sequences (CANNTG), but lacks detectable transcriptional activation activity; instead it represses transcriptional activity of myogenic bHLH proteins.","method":"Yeast two-hybrid screening, electrophoretic mobility shift assay (EMSA), transcriptional reporter assays","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro binding assays, reporter assays, and yeast two-hybrid reconstitution in the foundational paper; replicated in subsequent work","pmids":["7589808"],"is_preprint":false},{"year":2002,"finding":"TWIST2 (Dermo-1) represses MyoD-mediated transactivation through its HLH and C-terminal domains, directly interacts with MEF2 via its N- and C-terminal domains (but not the bHLH domain) to selectively repress the MEF2 transactivation domain, and recruits histone deacetylase activity to mediate chromatin-level repression (trichostatin A treatment reduces repression activity).","method":"Deletion mutagenesis of Dermo-1, transcriptional reporter assays, co-immunoprecipitation/direct protein interaction assays, HDAC inhibitor treatment","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (mutagenesis, reporter assays, protein interaction, pharmacological inhibition) in a single rigorous study","pmids":["11809751"],"is_preprint":false},{"year":2003,"finding":"TWIST2 physically interacts with ADD1/SREBP1c (identified by yeast two-hybrid and confirmed by co-immunoprecipitation) and represses ADD1/SREBP1c transcriptional activity primarily by reducing its DNA binding to target sequences; this repression is partially dependent on HDAC activity.","method":"Yeast two-hybrid with adipocyte cDNA library, co-immunoprecipitation, transcriptional reporter assays, HDAC inhibitor treatment","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — yeast two-hybrid plus co-immunoprecipitation plus reporter assays plus pharmacological dissection, single lab but multiple orthogonal methods","pmids":["14654692"],"is_preprint":false},{"year":2008,"finding":"TWIST2 inhibits the proliferation and differentiation of granulocyte-macrophage progenitors by interacting with and inhibiting the transcription factors Runx1 and C/EBPα; it also activates c-Maf transcription to promote IL-10 production while inhibiting IL-12 and IFNγ production; Twist2-deficient mice show marked increases in macrophages, neutrophils, and basophils.","method":"Twist-2 knockout mice, mechanistic studies with protein-protein interaction assays, gene expression analysis, cytokine measurements","journal":"PLoS biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function (knockout mice) with defined cellular phenotype plus mechanistic protein interaction studies","pmids":["19090621"],"is_preprint":false},{"year":2010,"finding":"Homozygous nonsense mutations in TWIST2 (c.324C>T [p.Q65X] and c.486C>T [p.Q119X]) cause Setleis syndrome; the expressed truncated mutant proteins are unstable and fail to bind DNA normally as shown by electrophoretic mobility shift assays and immunoblot analysis.","method":"Homozygosity mapping, gene sequencing, EMSA, immunoblot analysis of mutant proteins","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct biochemical characterization of mutant proteins by EMSA and immunoblot, corroborated by human genetics","pmids":["20691403"],"is_preprint":false},{"year":2010,"finding":"Canonical Wnt signaling/β-catenin is required and sufficient for Dermo1 (TWIST2) expression and dermal cell identity in the cranium; Dermo1 can be a direct transcriptional target of Wnt/β-catenin signaling in dermal precursors.","method":"Genetic fate mapping and conditional β-catenin gain/loss-of-function in mice, reporter gene assays","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis using conditional mouse knockouts and gain-of-function with defined phenotypic readout","pmids":["20980404"],"is_preprint":false},{"year":2011,"finding":"TWIST2 nonsense mutation Q119X maintains nuclear localization and homo/heterodimer formation with E12 and DNA binding, but fails to transactivate the periostin gene; the C-terminal domain of TWIST2 is required for proper transactivation and is associated with higher histone acetylation across the periostin 5'-regulatory region.","method":"Reporter gene assays with deletion constructs, EMSA, chromatin immunoprecipitation (ChIP), functional analysis in patient fibroblasts","journal":"The international journal of biochemistry & cell biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal methods (EMSA, reporter assays, ChIP) in patient-derived cells, single lab","pmids":["21801849"],"is_preprint":false},{"year":2013,"finding":"TWIST2 directly binds to the E-box region in the CD24 promoter to activate CD24 expression; Twist2-mediated promotion of liver cancer stem-like cell self-renewal operates through a CD24-STAT3-Nanog pathway.","method":"Chromatin immunoprecipitation (ChIP) of CD24 promoter, stable Twist2 overexpression and knockdown in HCC cells, in vitro/in vivo functional assays","journal":"Carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP assay plus functional rescue experiments, single lab","pmids":["24193512"],"is_preprint":false},{"year":2014,"finding":"LPS promotes PDCD4 degradation via PI3K/mTOR pathway, releasing TWIST2 from a PDCD4-TWIST2 complex; free TWIST2 then binds the c-Maf promoter to induce c-Maf mRNA and downstream IL-10 production in macrophages.","method":"Co-immunoprecipitation of PDCD4-TWIST2 complex, promoter binding assays, PI3K/mTOR inhibitor treatment, macrophage stimulation with LPS","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal co-immunoprecipitation plus promoter-binding assays plus pharmacological dissection, single lab with multiple orthogonal methods","pmids":["24982420"],"is_preprint":false},{"year":2014,"finding":"TWIST2 directly activates p21 transcription (requiring intact HLH domain) in human hematopoietic cells; overexpression inhibits AML cell growth partially through p21 induction, while hypermethylation of the TWIST2 promoter silences both TWIST2 and p21 in AML patients.","method":"Overexpression and knockdown experiments, cell cycle analysis, promoter methylation analysis (pyrosequencing/COBRA), gene expression microarray","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss/gain-of-function with mechanistic follow-up including domain requirements, single lab","pmids":["25088197"],"is_preprint":false},{"year":2015,"finding":"Recurrent de novo missense mutations in the basic domain of TWIST2 (at residue Glu75) cause Ablepharon macrostomia syndrome (Lys substitution) or Barber-Say syndrome (Gln or Ala substitution); these mutations alter the DNA-binding pattern of TWIST2 in HeLa cells.","method":"Whole exome sequencing, candidate gene sequencing, functional validation of Flag-TWIST2 DNA binding in HeLa cells, zebrafish expression studies","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — functional DNA-binding assays in cells, multiple independent families, genotype-phenotype correlation validated in zebrafish","pmids":["26119818"],"is_preprint":false},{"year":2015,"finding":"TWIST1 and TWIST2 bind to cytokine promoters during chronic NOD2 stimulation; they cooperate to enhance binding of c-Maf and Bmi1 to cytokine promoters while decreasing binding of transcriptional activators (ATF4, C/EBPα, Runx1, Runx2), thereby mediating cytokine downregulation in human macrophages.","method":"Chromatin immunoprecipitation of cytokine promoters, siRNA knockdown in primary human macrophages, rescue experiments with c-Maf and Bmi1 restoration","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus siRNA knockdown with rescue in primary human cells, single lab","pmids":["26019273"],"is_preprint":false},{"year":2016,"finding":"TWIST2 directly binds the E-cadherin promoter at the -714 bp region (but not the -295 bp region) to repress E-cadherin transcription; HIF-2α promotes EMT in pancreatic cancer by regulating Twist2 binding to the E-cadherin promoter.","method":"Chromatin immunoprecipitation (ChIP) assay, Western blot, siRNA knockdown","journal":"Journal of experimental & clinical cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP assay demonstrating direct promoter binding, single lab","pmids":["26842802"],"is_preprint":false},{"year":2017,"finding":"TWIST2 transcription factor directly binds the promoter of miR-221-3p to promote its expression; miR-221-3p then targets THBS2 mRNA to suppress its expression, forming a TWIST2→miR-221-3p→THBS2 axis promoting cervical cancer lymphatic metastasis.","method":"Chromatin immunoprecipitation (ChIP), luciferase reporter assays, miR-221-3p overexpression/inhibition in vitro and in vivo","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus reporter assays confirming direct promoter binding, single lab","pmids":["29242498"],"is_preprint":false},{"year":2017,"finding":"Lineage tracing reveals Twist2-expressing progenitor cells reside outside the basal lamina of adult skeletal muscle, are molecularly and anatomically distinct from Pax7+ satellite cells, contribute specifically to type IIb/x myofibres, and their genetic ablation causes wasting of type IIb myofibres; Tw2 expression maintains progenitors in an undifferentiated state.","method":"Tamoxifen-inducible lineage tracing (Twist2-CreERT2 x reporter mice), genetic ablation (diphtheria toxin), in vitro myogenesis assays, immunofluorescence, electron microscopy","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic lineage tracing plus genetic ablation with defined fiber-type-specific phenotype, multiple orthogonal methods","pmids":["28218909"],"is_preprint":false},{"year":2017,"finding":"De novo mutations at TWIST2 Glu117 (equivalent residue to TWIST1 Glu117) in the basic DNA-binding domain act via a predominantly dominant-negative mechanism as demonstrated by allelic series in C. elegans hlh-8, showing graded severity in gene expression and cellular phenotype.","method":"Targeted mutagenesis of C. elegans hlh-8 allelic series, gene expression analysis, cellular phenotype assessment","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic allelic series mutagenesis in C. elegans with functional readouts; ortholog model","pmids":["28369379"],"is_preprint":false},{"year":2019,"finding":"TWIST2 competes with MyoD at shared DNA motifs genome-wide (revealed by ChIP-seq) to direct global gene transcription and repression of the myogenic program; TWIST2 shapes the epigenetic landscape by driving chromatin opening at oncogenic loci and chromatin closing at myogenic loci, thereby redirecting MyoD binding from myogenic genes toward oncogenic/metabolic/growth genes in rhabdomyosarcoma.","method":"Inducible Twist2 expression system, genome-wide ChIP-seq, RNA-seq, ATAC-seq, knockdown in RMS cells","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1 / Strong — genome-wide ChIP-seq plus ATAC-seq plus RNA-seq in inducible system, multiple orthogonal methods","pmids":["30975722"],"is_preprint":false},{"year":2019,"finding":"Chronic NOD2 stimulation upregulates Twist1/Twist2, which bind to promoters of HDAC1 and HDAC3 to induce their expression; HDAC1 and HDAC3 then mediate histone deacetylation at cytokine promoters, resulting in cytokine downregulation (macrophage memory/tolerance).","method":"Chromatin immunoprecipitation of HDAC1/HDAC3 promoters, siRNA knockdown in primary human macrophages, histone acetylation assays, rescue experiments","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus knockdown plus rescue experiments in primary human cells, single lab","pmids":["31028123"],"is_preprint":false},{"year":2016,"finding":"In positively selected thymocytes, TWIST2 expression is induced via the Ca2+-Calcineurin-NFATc3 pathway; stronger TCR signals activating the JNK pathway abolish NFATc3-dependent Twist2 induction. Twist2 determines thymocyte sensitivity to TCR-mediated apoptosis by repressing Nur77 expression; mechanistically, Twist2 retains HDAC7 in the nucleus and recruits it to the Nur77 promoter.","method":"Twist2-deficient and transgenic mice, ChIP of Nur77 promoter, pharmacological pathway inhibition (calcineurin, JNK inhibitors), apoptosis assays","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic mouse models (KO and transgenic) plus ChIP plus pharmacological pathway dissection with defined phenotype","pmids":["27391798"],"is_preprint":false},{"year":2020,"finding":"During CD8 T-cell lineage differentiation, TWIST2 interacts with Runx3 and the complex binds to the silencer region of the ThPOK locus to block ThPOK expression, thereby promoting CD8+ thymocyte differentiation.","method":"Twist2-deficient mice, MHC class II-/- and TCR transgenic mouse models, protein-protein interaction assays (Twist2-Runx3), chromatin binding assays at ThPOK silencer","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic mouse models plus direct demonstration of Twist2-Runx3 interaction at ThPOK silencer","pmids":["32424141"],"is_preprint":false},{"year":2021,"finding":"ZNF451, a SUMO2/3-specific E3 ligase, directly binds TWIST2 and SUMOylates it at K129, thereby blocking ubiquitin-proteasome-dependent degradation and stabilizing TWIST2 protein to promote EMT.","method":"Co-immunoprecipitation, SUMOylation assays, site-directed mutagenesis (K129), ZNF451 overexpression/depletion in mammary epithelial cells, Western blot","journal":"American journal of cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical SUMOylation assay with identified site plus functional consequences, single lab","pmids":["33791162"],"is_preprint":false},{"year":2022,"finding":"TWIST2 drives postnatal maturation of papillary dermal fibroblasts through extensive chromatin remodeling; genetic deletion of Twist2 in dermal fibroblasts delays the postnatal loss of regenerative ability, which is characterized by decreased H3K27ac levels and decreased chromatin accessibility.","method":"Single-cell transcriptomics, ATAC-seq, ChIP-seq, genetic Twist2 deletion in dermal fibroblasts, HDAC inhibitor treatment","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO plus ATAC-seq plus ChIP-seq with multiple orthogonal genomic and functional readouts","pmids":["35584664"],"is_preprint":false},{"year":2023,"finding":"TWIST2 controls H3K27 acetylation at distal enhancers in fusion-negative rhabdomyosarcoma by interacting with chromatin remodelers SMARCA4 and CHD3, activating growth-related target genes and repressing myogenesis-related target genes; TWIST2 knockdown enables FN-RMS cells to exit the cell cycle and undergo terminal myogenesis.","method":"Co-immunoprecipitation of TWIST2 with SMARCA4 and CHD3, ChIP-seq for H3K27ac, RNA-seq, shRNA knockdown, mouse xenograft model","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP identifying SMARCA4/CHD3 partners plus ChIP-seq plus RNA-seq plus in vivo xenograft, multiple orthogonal methods","pmids":["37115930"],"is_preprint":false},{"year":2023,"finding":"TWIST2 acts as a negative regulator of adipocyte differentiation in 3T3-L1 and primary preadipocytes; Twist2 knockout mice have compromised lipid storage in subcutaneous and brown adipose tissue.","method":"Kinetic ATAC-seq and PRO-seq (nascent transcription) network analysis, Twist2 knockout mice, adipocyte differentiation assays","journal":"Genome research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO mice with tissue phenotype plus temporal chromatin/transcription data, single lab","pmids":["36810156"],"is_preprint":false},{"year":2012,"finding":"TWIST2 overexpression in chick limb bud (RCAS-mediated) causes hypoplastic limb phenotypes through premature termination of limb outgrowth; TWIST2 directly represses Grem1 expression via a regulatory element downstream of the Grem1 open reading frame, thereby downregulating the Shh/Grem1/Fgf autoregulatory loop; co-expression of Grem1 rescues the Twist2 overexpression phenotype.","method":"RCAS retroviral misexpression in chick limb, in situ hybridization, direct regulatory element analysis (reporter/binding assays), genetic rescue with Grem1 co-expression","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function with genetic rescue plus direct regulatory element analysis, single lab","pmids":["22884497"],"is_preprint":false},{"year":2014,"finding":"The first TWIST2 missense mutation (p.Leu109Pro) causing Setleis syndrome is predicted by in silico modeling to increase unfavorable force field energy; the proline substitution is located near the dimer interface and is predicted to hinder dimer formation, thereby preventing TWIST2 from binding target genes.","method":"Homozygosity mapping, gene sequencing, in silico structural modeling on crystallographically generated dimer","journal":"Clinical genetics","confidence":"Low","confidence_rationale":"Tier 4 / Weak — structural inference is purely in silico/computational; no experimental biochemical validation of dimerization defect","pmids":["25410422"],"is_preprint":false},{"year":2019,"finding":"KLF15 directly interacts with the Twist2 promoter to activate TWIST2 expression; SREBP1c and FOXO1 repress TWIST2 expression; TWIST2 overexpression inhibits NF-κB nuclear translocation and binding to the FGF21 promoter, thereby de-repressing FGF21 expression to ameliorate hepatic steatosis.","method":"ChIP assays on Twist2 and FGF21 promoters, TWIST2 overexpression and knockdown in hepatocytes, in vivo mouse knockdown model","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP assays plus in vivo and in vitro functional experiments, single lab","pmids":["31648561"],"is_preprint":false},{"year":2023,"finding":"TWIST2 and ADD1/SREBP1c compete for binding to the same E-box in the CHRDL1 gene upstream region; TWIST2 (but not TWIST2-Q119X mutant) blocks ADD1/SREBP1c-mediated activation of CHRDL1, while the Q119X mutant may form an inactive complex with ADD1/SREBP1c that allows other activators to increase CHRDL1 expression.","method":"EMSA (homo/heterodimer binding assays), EMSA competition assays, luciferase reporter assays, patient fibroblast/lymphoblast expression analysis","journal":"Genes","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — EMSA and reporter assays with mutant and wild-type proteins, single lab","pmids":["37761873"],"is_preprint":false},{"year":2025,"finding":"TWIST2 directly inhibits Bnip3 transcriptional activity by binding the Bnip3 promoter; TWIST2 knockdown alleviates renal ischemia-reperfusion injury by improving mitochondrial function and enhancing mitophagy through de-repression of Bnip3.","method":"RNAi knockdown in mice and HK-2 cells, promoter binding assay (luciferase/ChIP implied), mitochondrial function assays, autophagy markers, electron microscopy","journal":"Human cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KD in vivo and in vitro with mechanistic rescue experiments, single lab","pmids":["39918659"],"is_preprint":false},{"year":2025,"finding":"HOXA10 directly represses TWIST2 in endometrial luminal epithelium; HOXA10 loss de-represses TWIST2 to induce partial EMT and increased cell motility; TWIST2 knockdown restores epithelial identity and impairs embryo implantation; CUT&RUN and transcriptomic profiling confirm HOXA10 directly activates epithelial gene networks and represses mesenchymal programs including TWIST2.","method":"CUT&RUN, transcriptomic profiling, siRNA knockdown of HOXA10 and TWIST2 in human endometrial cells, in vivo mouse implantation model","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CUT&RUN plus transcriptomics plus in vivo functional assays, single lab","pmids":["41213962"],"is_preprint":false},{"year":2014,"finding":"TWIST2 promotes survival of ovarian cancer cells under hypoxic conditions through activation of Akt (PI3K-Akt pathway); Twist2-overexpressing cells show increased Akt phosphorylation under DFO-induced hypoxic stress, reducing apoptosis.","method":"Stable Twist2 overexpression in SKOV-3 cells, DFO-induced hypoxia simulation, flow cytometry for apoptosis, Western blot for Akt phosphorylation","journal":"Oncology letters","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single-method overexpression with Western blot readout, no direct mechanistic dissection of how TWIST2 activates Akt","pmids":["23946798"],"is_preprint":false},{"year":2009,"finding":"TWIST2 downregulates CD7 gene promoter activity through its C-terminal domain, and recruits histone deacetylase activity (sensitive to TSA and sodium butyrate); ectopic Twist2 expression in Jurkat cells reduces galectin-1-induced apoptosis.","method":"Promoter reporter assays with C-terminal deletion mutants, HDAC inhibitor treatment (TSA, sodium butyrate), ectopic Twist2 expression, apoptosis assays","journal":"Molecules and cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reporter assays with deletion mutagenesis plus pharmacological HDAC inhibition, single lab","pmids":["19937140"],"is_preprint":false},{"year":2014,"finding":"TWIST2 downregulation in Twist2-siRNA-treated ovarian cancer cells sensitizes them to cisplatin; conversely, TWIST2 overexpression promotes cisplatin resistance through the AKT/GSK-3β signaling pathway.","method":"Plasmid overexpression and siRNA knockdown in OV2008/C13K cells, cell viability assays, apoptosis analysis, Western blot for pAKT/pGSK-3β","journal":"Oncology letters","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single-method overexpression/knockdown with pathway marker readout, no direct mechanistic link established","pmids":["24944676"],"is_preprint":false},{"year":2017,"finding":"A structural variant (quadruplication of a 6 kb non-coding sequence ~16 kb upstream of TWIST2) causes aberrant TWIST2 expression during neural crest development; ectopic expression of bovine TWIST2 in neural crest in transgenic zebrafish leads to decreased melanocyte numbers, implicating TWIST2 in regulating pigmentation.","method":"Whole genome sequencing, copy number variant analysis, transgenic zebrafish with ectopic TWIST2 expression in neural crest","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional transgenic zebrafish experiment with defined phenotypic readout, single lab","pmids":["28658273"],"is_preprint":false},{"year":2010,"finding":"In osteoblastic cells, Twist2 haploinsufficiency reduces Fgf2 and Fgfr1-4 expression; both Twist1 and Twist2 stimulate 4.9 kb Fgfr2 promoter activity in the presence of the Twist binding partner E12, indicating TWIST2 directly regulates FGF signaling components.","method":"Conditional haploinsufficient mouse model (Twist1f/+;Twist2Cre/+), dual luciferase reporter assays with E12, in situ hybridization, real-time PCR","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic mouse model plus reporter assay in presence of E12 dimerization partner, single lab","pmids":["24971743"],"is_preprint":false}],"current_model":"TWIST2 (DERMO1/bHLHa39) is a basic helix-loop-helix transcription factor that forms homodimers and E12 heterodimers to bind E-box sequences, functioning primarily as a transcriptional repressor by recruiting HDAC activity (via HDAC1/3/7) and competing with activators (MyoD, MEF2, C/EBPα, Runx1, ADD1/SREBP1c) at shared DNA motifs; it regulates mesenchymal cell lineage decisions (dermis, bone, muscle, myeloid, lymphoid), controls chromatin accessibility at myogenic vs. oncogenic loci through interactions with SMARCA4 and CHD3, modulates inflammatory responses in macrophages through c-Maf/IL-10 and PDCD4-dependent mechanisms, is stabilized post-translationally by ZNF451-mediated SUMOylation at K129, and is required for type IIb/x skeletal muscle fibre maintenance, with loss-of-function mutations causing Setleis, Ablepharon macrostomia, and Barber-Say syndromes."},"narrative":{"mechanistic_narrative":"TWIST2 (Dermo-1) is a basic helix-loop-helix transcription factor that dimerizes with the ubiquitous bHLH protein E12 to bind E-box (CANNTG) motifs and acts predominantly as a transcriptional repressor that controls mesenchymal lineage decisions across dermis, muscle, bone, and hematopoietic compartments [PMID:7589808, PMID:24971743]. Lacking intrinsic activation activity, it represses target loci by recruiting histone deacetylase activity (HDAC-inhibitor-sensitive) and by competing with or directly antagonizing lineage-specifying activators including the myogenic factors MyoD and MEF2, ADD1/SREBP1c, Runx1, and C/EBPα at shared DNA elements [PMID:11809751, PMID:14654692, PMID:19090621, PMID:37761873]. At genome scale TWIST2 shapes the epigenetic landscape: it competes with MyoD across the genome to close myogenic loci and open growth/oncogenic loci, and it controls H3K27 acetylation at distal enhancers through physical interaction with the chromatin remodelers SMARCA4 and CHD3, thereby sustaining proliferation and blocking terminal myogenesis in fusion-negative rhabdomyosarcoma [PMID:30975722, PMID:37115930]. The same chromatin-remodeling activity drives postnatal maturation of dermal fibroblasts by reorganizing accessibility and H3K27ac [PMID:35584664]. In adult skeletal muscle, Twist2 marks a satellite-cell-independent progenitor population that maintains type IIb/x myofibres and holds these progenitors in an undifferentiated state [PMID:28218909]. TWIST2 also operates as a context-dependent activator and immune modulator, inducing c-Maf to promote IL-10 while restraining inflammatory cytokines in macrophages—a function gated by release from a PDCD4–TWIST2 complex—and shaping thymocyte selection and CD8 lineage commitment through repression of Nur77 (via nuclear retention of HDAC7) and ThPOK (via a Runx3 complex) [PMID:19090621, PMID:24982420, PMID:27391798, PMID:32424141]. TWIST2 protein stability is regulated by ZNF451-mediated SUMOylation at K129, which blocks proteasomal degradation [PMID:33791162]. Loss-of-function nonsense mutations cause Setleis syndrome, while recurrent de novo missense mutations in the basic DNA-binding domain (residue Glu75) cause Ablepharon macrostomia and Barber-Say syndromes by altering DNA-binding specificity [PMID:20691403, PMID:26119818].","teleology":[{"year":1995,"claim":"Established the founding biochemical identity of TWIST2 as an E12-dimerizing E-box-binding bHLH factor that represses rather than activates, defining its core molecular mode of action.","evidence":"Yeast two-hybrid, EMSA, and reporter assays defining E12 dimerization and repression of myogenic bHLH proteins","pmids":["7589808"],"confidence":"High","gaps":["Direct target genes in vivo not yet identified","Mechanism of repression (cofactor recruitment) not yet defined"]},{"year":2002,"claim":"Resolved how TWIST2 represses the myogenic program by mapping the domains that bind MyoD and MEF2 and demonstrating HDAC-dependent chromatin-level repression.","evidence":"Deletion mutagenesis, co-IP, reporter assays, and TSA treatment in transcription assays","pmids":["11809751"],"confidence":"High","gaps":["Specific HDAC isoforms not identified","Endogenous target loci not mapped"]},{"year":2003,"claim":"Extended TWIST2 repression to lipogenic transcription by showing it binds ADD1/SREBP1c and reduces its DNA binding, linking TWIST2 to adipocyte gene control.","evidence":"Yeast two-hybrid with adipocyte cDNA library, co-IP, reporter assays, HDAC inhibitor dissection","pmids":["14654692"],"confidence":"High","gaps":["In vivo relevance to adipogenesis not tested in this study","Shared genomic targets not defined"]},{"year":2008,"claim":"Demonstrated in vivo that TWIST2 restrains myeloid lineage output and reprograms cytokine balance, establishing a hematopoietic/immune regulatory role.","evidence":"Twist2-knockout mice with protein-interaction assays against Runx1/C/EBPα and cytokine measurements","pmids":["19090621"],"confidence":"High","gaps":["Direct genomic binding sites for c-Maf activation not mapped here","How TWIST2 switches between repression and c-Maf activation unresolved"]},{"year":2010,"claim":"Connected TWIST2 to human disease and to its upstream regulation, showing nonsense mutations cause Setleis syndrome and that Wnt/β-catenin drives Dermo1 expression in dermal identity.","evidence":"Homozygosity mapping with EMSA/immunoblot of mutant proteins; conditional β-catenin gain/loss mouse genetics","pmids":["20691403","20980404"],"confidence":"High","gaps":["Whether truncations are pure loss-of-function or dominant-negative not resolved here","Direct β-catenin binding element on Dermo1 not fully defined"]},{"year":2011,"claim":"Distinguished the activation versus repression functions of TWIST2 domains by showing the disease mutant Q119X retains dimerization and DNA binding but fails to transactivate periostin.","evidence":"Reporter assays with deletion constructs, EMSA, ChIP, and patient fibroblast analysis","pmids":["21801849"],"confidence":"High","gaps":["Coactivators recruited by the C-terminal domain not identified","Generality of activation function beyond periostin unclear"]},{"year":2013,"claim":"Identified TWIST2 as a direct E-box activator of CD24 driving cancer stem-cell self-renewal, broadening its role to oncogenic transcriptional activation.","evidence":"ChIP of CD24 promoter with overexpression/knockdown and functional assays in HCC cells","pmids":["24193512"],"confidence":"Medium","gaps":["Single-lab ChIP without genome-wide validation","Cofactor basis of activation vs repression context unresolved"]},{"year":2014,"claim":"Defined post-transcriptional control of TWIST2 activity in macrophages, showing PDCD4 sequesters TWIST2 and LPS-driven PDCD4 degradation releases it to induce c-Maf/IL-10.","evidence":"Reciprocal co-IP of PDCD4-TWIST2, promoter binding assays, PI3K/mTOR inhibition, LPS stimulation","pmids":["24982420"],"confidence":"High","gaps":["Structural basis of PDCD4-TWIST2 interaction unknown","Whether sequestration generalizes beyond macrophages untested"]},{"year":2014,"claim":"Linked TWIST2 to cell-cycle control in hematopoietic malignancy by showing HLH-dependent direct activation of p21 and epigenetic silencing in AML.","evidence":"Overexpression/knockdown, cell-cycle analysis, promoter methylation analysis in AML samples","pmids":["25088197"],"confidence":"Medium","gaps":["Direct p21 promoter occupancy not shown by ChIP here","Reconciliation of activator role with canonical repression unaddressed"]},{"year":2015,"claim":"Established a second mutation class — recurrent de novo basic-domain missense at Glu75 — causing Ablepharon macrostomia and Barber-Say syndromes by altering DNA-binding pattern.","evidence":"Whole exome sequencing, Flag-TWIST2 DNA-binding assays in HeLa, zebrafish expression","pmids":["26119818"],"confidence":"High","gaps":["Precise mechanistic basis (gain vs altered specificity) only partly resolved","Affected target gene set in disease tissue not defined"]},{"year":2015,"claim":"Expanded the macrophage repression mechanism by showing TWIST1/TWIST2 cooperatively remodel cytokine promoter occupancy, recruiting c-Maf/Bmi1 and displacing activators.","evidence":"ChIP of cytokine promoters with siRNA knockdown and c-Maf/Bmi1 rescue in primary human macrophages","pmids":["26019273"],"confidence":"Medium","gaps":["Direct vs cooperative binding contributions of TWIST2 alone unclear","Single-lab ChIP without orthogonal genomic mapping"]},{"year":2016,"claim":"Demonstrated TWIST2 represses E-cadherin via a defined promoter element downstream of hypoxic HIF-2α signaling, implicating it in EMT.","evidence":"ChIP mapping of E-cadherin promoter, Western blot, siRNA in pancreatic cancer cells","pmids":["26842802"],"confidence":"Medium","gaps":["Cofactor/HDAC involvement at E-cadherin not dissected","Direct HIF-2α-to-TWIST2 mechanistic link incomplete"]},{"year":2016,"claim":"Placed TWIST2 in T-cell selection by showing NFATc3-driven induction and TWIST2-dependent repression of Nur77 via nuclear retention and recruitment of HDAC7.","evidence":"Twist2-KO and transgenic mice, ChIP of Nur77 promoter, calcineurin/JNK inhibition, apoptosis assays","pmids":["27391798"],"confidence":"High","gaps":["Direct HDAC7-TWIST2 binding interface not mapped","Generalization to peripheral T cells untested"]},{"year":2017,"claim":"Defined a distinct adult muscle stem-cell function, identifying Twist2+ progenitors outside the basal lamina that maintain type IIb/x fibres and stay undifferentiated under Twist2 control.","evidence":"Inducible lineage tracing, diphtheria-toxin ablation, in vitro myogenesis, imaging in mice","pmids":["28218909"],"confidence":"High","gaps":["Transcriptional targets sustaining the undifferentiated state not mapped","Relationship to satellite-cell signaling unclear"]},{"year":2017,"claim":"Clarified disease genetics by showing basic-domain mutations act through a predominantly dominant-negative mechanism via a graded allelic series in the ortholog.","evidence":"C. elegans hlh-8 allelic series mutagenesis with expression and phenotype readouts","pmids":["28369379"],"confidence":"Medium","gaps":["Dominant-negative mechanism inferred in ortholog, not human TWIST2 directly","Molecular basis of interference with wild-type dimers not shown"]},{"year":2017,"claim":"Added metastasis-promoting activator function via a TWIST2→miR-221-3p→THBS2 axis and implicated non-coding upstream regulation in pigmentation phenotypes.","evidence":"ChIP and luciferase assays for miR-221-3p (cervical cancer); WGS/CNV with transgenic zebrafish neural-crest expression","pmids":["29242498","28658273"],"confidence":"Medium","gaps":["Single-lab promoter assays","Causal regulatory element architecture upstream of TWIST2 incompletely defined"]},{"year":2019,"claim":"Provided the genome-wide mechanism by which TWIST2 reprograms cell fate, competing with MyoD to redirect chromatin accessibility from myogenic to oncogenic loci.","evidence":"Inducible expression with ChIP-seq, ATAC-seq, RNA-seq, and knockdown in rhabdomyosarcoma cells","pmids":["30975722"],"confidence":"High","gaps":["Chromatin-remodeling cofactors mediating opening/closing not yet identified here","Determinants of locus-specific opening vs closing unclear"]},{"year":2019,"claim":"Extended the HDAC-repression theme by showing TWIST factors transcriptionally induce HDAC1/HDAC3 to deacetylate cytokine promoters during macrophage tolerance.","evidence":"ChIP of HDAC1/HDAC3 promoters, siRNA knockdown and rescue, histone acetylation assays in human macrophages","pmids":["31028123"],"confidence":"Medium","gaps":["TWIST2-specific (vs TWIST1) contribution not isolated","Single-lab ChIP without genome-wide confirmation"]},{"year":2019,"claim":"Identified upstream transcriptional regulators of TWIST2 and a hepatic anti-inflammatory output via NF-κB inhibition and FGF21 de-repression.","evidence":"ChIP on Twist2 and FGF21 promoters with overexpression/knockdown and in vivo mouse knockdown","pmids":["31648561"],"confidence":"Medium","gaps":["Mechanism of NF-κB nuclear translocation block not defined","Single-lab data"]},{"year":2020,"claim":"Revealed a partner-dependent lineage decision in which TWIST2-Runx3 complexes block ThPOK at its silencer to drive CD8 commitment.","evidence":"Multiple genetic mouse models with Twist2-Runx3 interaction and ThPOK silencer binding assays","pmids":["32424141"],"confidence":"High","gaps":["Structural basis of TWIST2-Runx3 complex unknown","Whether HDAC recruitment is involved untested"]},{"year":2021,"claim":"Defined post-translational stabilization of TWIST2 by ZNF451-mediated SUMOylation at K129 that blocks proteasomal degradation and promotes EMT.","evidence":"Co-IP, SUMOylation assays, K129 mutagenesis, ZNF451 manipulation in mammary epithelial cells","pmids":["33791162"],"confidence":"Medium","gaps":["Single-lab biochemistry","In vivo relevance of K129 SUMOylation untested"]},{"year":2022,"claim":"Showed TWIST2 drives postnatal dermal fibroblast maturation through chromatin remodeling, with its loss preserving regenerative chromatin states.","evidence":"Single-cell transcriptomics, ATAC-seq, ChIP-seq, genetic Twist2 deletion, HDAC inhibitor treatment","pmids":["35584664"],"confidence":"High","gaps":["Direct cofactors mediating remodeling not identified here","Reversibility of the maturation program unexplored"]},{"year":2023,"claim":"Identified the chromatin-remodeling partners (SMARCA4, CHD3) through which TWIST2 controls enhancer H3K27ac to sustain oncogenic growth and block myogenesis in FN-RMS.","evidence":"Reciprocal co-IP, H3K27ac ChIP-seq, RNA-seq, shRNA knockdown, mouse xenograft","pmids":["37115930"],"confidence":"High","gaps":["How TWIST2 selects activating vs repressive enhancers not resolved","Stoichiometry of the TWIST2-SMARCA4-CHD3 assembly unknown"]},{"year":2023,"claim":"Defined TWIST2 as a negative regulator of adipocyte differentiation through temporal chromatin/transcription remodeling, with KO mice showing reduced lipid storage; and reaffirmed direct ADD1/SREBP1c competition at a shared E-box (CHRDL1).","evidence":"ATAC-seq/PRO-seq network analysis and KO mice (adipocyte); EMSA competition and reporter assays with WT vs Q119X (CHRDL1)","pmids":["36810156","37761873"],"confidence":"Medium","gaps":["Direct adipogenic target genes not pinpointed","Single-lab biochemistry for CHRDL1 competition"]},{"year":2025,"claim":"Extended TWIST2 repression to mitochondrial quality control and epithelial identity, repressing Bnip3 (renal injury/mitophagy) and being repressed by HOXA10 to restrain EMT in endometrium.","evidence":"RNAi in mice/HK-2 cells with promoter binding and mitophagy assays; CUT&RUN, transcriptomics, siRNA, and mouse implantation model","pmids":["39918659","41213962"],"confidence":"Medium","gaps":["Direct ChIP-grade binding mapping limited","Single-lab studies for each axis"]},{"year":null,"claim":"How TWIST2 toggles between transcriptional repression and activation at different loci and cell contexts — including the structural determinants of cofactor (HDAC, SMARCA4/CHD3, Runx3) selection and the rules governing locus-specific chromatin opening vs closing — remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of TWIST2-cofactor complexes","Determinants of activator vs repressor switching not defined","Integration of post-translational control (SUMOylation) with genomic targeting unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,16,22]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,4,6,10]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[2,18,31]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[6,18]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[16,22]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,16]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[16,21,22]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[5,14,24,34]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[3,8,18,19]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[4,10]}],"complexes":[],"partners":["E12","MYOD","MEF2","ADD1/SREBP1C","PDCD4","RUNX3","SMARCA4","CHD3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q8WVJ9","full_name":"Twist-related protein 2","aliases":["Class A basic helix-loop-helix protein 39","bHLHa39","Dermis-expressed protein 1","Dermo-1"],"length_aa":160,"mass_kda":18.1,"function":"Binds to the E-box consensus sequence 5'-CANNTG-3' as a heterodimer and inhibits transcriptional activation by MYOD1, MYOG, MEF2A and MEF2C. Also represses expression of pro-inflammatory cytokines such as TNFA and IL1B. Involved in postnatal glycogen storage and energy metabolism (By similarity). Inhibits the premature or ectopic differentiation of preosteoblast cells during osteogenesis, possibly by changing the internal signal transduction response of osteoblasts to external growth factors","subcellular_location":"Nucleus; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q8WVJ9/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/TWIST2","classification":"Not Classified","n_dependent_lines":6,"n_total_lines":1208,"dependency_fraction":0.004966887417218543},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/TWIST2","total_profiled":1310},"omim":[{"mim_id":"617746","title":"SWEENEY-COX SYNDROME; SWCOS","url":"https://www.omim.org/entry/617746"},{"mim_id":"614974","title":"FOCAL FACIAL DERMAL DYSPLASIA 4; FFDD4","url":"https://www.omim.org/entry/614974"},{"mim_id":"608428","title":"CYTOCHROME P450, SUBFAMILY XXVIC, POLYPEPTIDE 1; CYP26C1","url":"https://www.omim.org/entry/608428"},{"mim_id":"607556","title":"TWIST FAMILY bHLH TRANSCRIPTION FACTOR 2; TWIST2","url":"https://www.omim.org/entry/607556"},{"mim_id":"605314","title":"HISTONE DEACETYLASE 4; HDAC4","url":"https://www.omim.org/entry/605314"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nucleoli","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"cervix","ntpm":81.7}],"url":"https://www.proteinatlas.org/search/TWIST2"},"hgnc":{"alias_symbol":["DERMO1","Dermo-1","bHLHa39"],"prev_symbol":[]},"alphafold":{"accession":"Q8WVJ9","domains":[{"cath_id":"4.10.280","chopping":"60-150","consensus_level":"medium","plddt":92.3931,"start":60,"end":150}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8WVJ9","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8WVJ9-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8WVJ9-F1-predicted_aligned_error_v6.png","plddt_mean":73.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=TWIST2","jax_strain_url":"https://www.jax.org/strain/search?query=TWIST2"},"sequence":{"accession":"Q8WVJ9","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8WVJ9.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8WVJ9/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8WVJ9"}},"corpus_meta":[{"pmid":"7589808","id":"PMC_7589808","title":"Dermo-1: a novel twist-related bHLH protein expressed in the developing dermis.","date":"1995","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/7589808","citation_count":231,"is_preprint":false},{"pmid":"21602879","id":"PMC_21602879","title":"Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal.","date":"2011","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/21602879","citation_count":168,"is_preprint":false},{"pmid":"20935057","id":"PMC_20935057","title":"Redundant or separate entities?--roles of Twist1 and Twist2 as molecular switches during gene transcription.","date":"2010","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/20935057","citation_count":144,"is_preprint":false},{"pmid":"28218909","id":"PMC_28218909","title":"A Twist2-dependent progenitor cell contributes to adult skeletal muscle.","date":"2017","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/28218909","citation_count":118,"is_preprint":false},{"pmid":"29242498","id":"PMC_29242498","title":"MicroRNA-221-3p, a TWIST2 target, promotes cervical cancer metastasis by directly targeting THBS2.","date":"2017","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/29242498","citation_count":87,"is_preprint":false},{"pmid":"24171926","id":"PMC_24171926","title":"Down-regulation of miR-138 promotes colorectal cancer metastasis via directly targeting TWIST2.","date":"2013","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24171926","citation_count":80,"is_preprint":false},{"pmid":"15809452","id":"PMC_15809452","title":"TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia.","date":"2005","source":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/15809452","citation_count":74,"is_preprint":false},{"pmid":"11062344","id":"PMC_11062344","title":"Human Dermo-1 has attributes similar to twist in early bone development.","date":"2000","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/11062344","citation_count":73,"is_preprint":false},{"pmid":"26842802","id":"PMC_26842802","title":"HIF-2α promotes epithelial-mesenchymal transition through regulating Twist2 binding to the promoter of E-cadherin in pancreatic cancer.","date":"2016","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/26842802","citation_count":69,"is_preprint":false},{"pmid":"11809751","id":"PMC_11809751","title":"Dermo-1, a multifunctional basic helix-loop-helix protein, represses MyoD transactivation via the HLH domain, MEF2 interaction, and chromatin deacetylation.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11809751","citation_count":64,"is_preprint":false},{"pmid":"22018873","id":"PMC_22018873","title":"Correlation of TWIST2 up-regulation and epithelial-mesenchymal transition during tumorigenesis and progression of cervical carcinoma.","date":"2011","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22018873","citation_count":62,"is_preprint":false},{"pmid":"24193512","id":"PMC_24193512","title":"Twist2 promotes self-renewal of liver cancer stem-like cells by regulating CD24.","date":"2013","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/24193512","citation_count":61,"is_preprint":false},{"pmid":"20980404","id":"PMC_20980404","title":"Role of canonical Wnt signaling/ß-catenin via Dermo1 in cranial dermal cell development.","date":"2010","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/20980404","citation_count":61,"is_preprint":false},{"pmid":"19090621","id":"PMC_19090621","title":"Twist-2 controls myeloid lineage development and function.","date":"2008","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/19090621","citation_count":58,"is_preprint":false},{"pmid":"27099513","id":"PMC_27099513","title":"Twist2 promotes kidney cancer cell proliferation and invasion by regulating ITGA6 and CD44 expression in the ECM-receptor interaction pathway.","date":"2016","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/27099513","citation_count":57,"is_preprint":false},{"pmid":"24244294","id":"PMC_24244294","title":"The role of nuclear β-catenin accumulation in the Twist2-induced ovarian cancer EMT.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24244294","citation_count":56,"is_preprint":false},{"pmid":"20691403","id":"PMC_20691403","title":"Homozygous nonsense mutations in TWIST2 cause Setleis syndrome.","date":"2010","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20691403","citation_count":52,"is_preprint":false},{"pmid":"24982420","id":"PMC_24982420","title":"LPS induces the degradation of programmed cell death protein 4 (PDCD4) to release Twist2, activating c-Maf transcription to promote interleukin-10 production.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24982420","citation_count":51,"is_preprint":false},{"pmid":"14654692","id":"PMC_14654692","title":"Twist2, a novel ADD1/SREBP1c interacting protein, represses the transcriptional activity of ADD1/SREBP1c.","date":"2003","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/14654692","citation_count":49,"is_preprint":false},{"pmid":"26119818","id":"PMC_26119818","title":"Recurrent Mutations in the Basic Domain of TWIST2 Cause Ablepharon Macrostomia and Barber-Say Syndromes.","date":"2015","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26119818","citation_count":47,"is_preprint":false},{"pmid":"23763516","id":"PMC_23763516","title":"Low osteogenic differentiation potential of placenta-derived mesenchymal stromal cells correlates with low expression of the transcription factors Runx2 and Twist2.","date":"2013","source":"Stem cells and development","url":"https://pubmed.ncbi.nlm.nih.gov/23763516","citation_count":39,"is_preprint":false},{"pmid":"22058208","id":"PMC_22058208","title":"Epigenetic inactivation of TWIST2 in acute lymphoblastic leukemia modulates proliferation, cell survival and chemosensitivity.","date":"2011","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/22058208","citation_count":36,"is_preprint":false},{"pmid":"30975722","id":"PMC_30975722","title":"Twist2 amplification in rhabdomyosarcoma represses myogenesis and promotes oncogenesis by redirecting MyoD DNA binding.","date":"2019","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/30975722","citation_count":34,"is_preprint":false},{"pmid":"31178137","id":"PMC_31178137","title":"Long non-coding RNA CASC9 enhances breast cancer progression by promoting metastasis through the meditation of miR-215/TWIST2 signaling associated with TGF-β expression.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31178137","citation_count":32,"is_preprint":false},{"pmid":"20448405","id":"PMC_20448405","title":"Potential involvement of Twist2 and Erk in the regulation of osteoblastogenesis by HB-EGF-EGFR signaling.","date":"2010","source":"Cell structure and function","url":"https://pubmed.ncbi.nlm.nih.gov/20448405","citation_count":31,"is_preprint":false},{"pmid":"22103974","id":"PMC_22103974","title":"Coexpression of hypoxia-inducible factor-2α, TWIST2, and SIP1 may correlate with invasion and metastasis of salivary adenoid cystic carcinoma.","date":"2011","source":"Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22103974","citation_count":30,"is_preprint":false},{"pmid":"24971743","id":"PMC_24971743","title":"Twist1- and Twist2-haploinsufficiency results in reduced bone formation.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24971743","citation_count":29,"is_preprint":false},{"pmid":"10022499","id":"PMC_10022499","title":"Identification of DERMO-1 as a member of helix-loop-helix type transcription factors expressed in osteoblastic cells.","date":"1999","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10022499","citation_count":28,"is_preprint":false},{"pmid":"23133563","id":"PMC_23133563","title":"Significance of heterogeneous Twist2 expression in human breast cancers.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23133563","citation_count":26,"is_preprint":false},{"pmid":"31648561","id":"PMC_31648561","title":"KLF15-activating Twist2 ameliorated hepatic steatosis by inhibiting inflammation and improving mitochondrial dysfunction via NF-κB-FGF21 or SREBP1c-FGF21 pathway.","date":"2019","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/31648561","citation_count":26,"is_preprint":false},{"pmid":"20673822","id":"PMC_20673822","title":"Isolation of murine bone marrow derived mesenchymal stem cells using Twist2 Cre transgenic mice.","date":"2010","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/20673822","citation_count":26,"is_preprint":false},{"pmid":"35584664","id":"PMC_35584664","title":"Twist2-driven chromatin remodeling governs the postnatal maturation of dermal fibroblasts.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/35584664","citation_count":25,"is_preprint":false},{"pmid":"21931173","id":"PMC_21931173","title":"Setleis syndrome in Mexican-Nahua sibs due to a homozygous TWIST2 frameshift mutation and partial expression in heterozygotes: review of the focal facial dermal dysplasias and subtype reclassification.","date":"2011","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21931173","citation_count":25,"is_preprint":false},{"pmid":"33206629","id":"PMC_33206629","title":"LINC01235-TWIST2 feedback loop facilitates epithelial-mesenchymal transition in gastric cancer by inhibiting THBS2.","date":"2020","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/33206629","citation_count":24,"is_preprint":false},{"pmid":"25088197","id":"PMC_25088197","title":"Regulation of p21 by TWIST2 contributes to its tumor-suppressor function in human acute myeloid leukemia.","date":"2014","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/25088197","citation_count":24,"is_preprint":false},{"pmid":"28369379","id":"PMC_28369379","title":"Localized TWIST1 and TWIST2 basic domain substitutions cause four distinct human diseases that can be modeled in Caenorhabditis elegans.","date":"2017","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28369379","citation_count":24,"is_preprint":false},{"pmid":"27261625","id":"PMC_27261625","title":"RETRACTED: Twist2 promotes kidney cancer cell proliferation and invasion via regulating ITGA6 and CD44 expression in the ECM-Receptor-Interaction pathway.","date":"2016","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/27261625","citation_count":23,"is_preprint":false},{"pmid":"33791162","id":"PMC_33791162","title":"ZNF451 stabilizes TWIST2 through SUMOylation and promotes epithelial-mesenchymal transition.","date":"2021","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/33791162","citation_count":22,"is_preprint":false},{"pmid":"23557174","id":"PMC_23557174","title":"Twist2 functions as a tumor suppressor in murine osteosarcoma cells.","date":"2013","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/23557174","citation_count":22,"is_preprint":false},{"pmid":"19937140","id":"PMC_19937140","title":"Twist2 regulates CD7 expression and galectin-1-induced apoptosis in mature T-cells.","date":"2009","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/19937140","citation_count":21,"is_preprint":false},{"pmid":"25663706","id":"PMC_25663706","title":"TWIST1 and TWIST2 regulate glycogen storage and inflammatory genes in skeletal muscle.","date":"2015","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/25663706","citation_count":21,"is_preprint":false},{"pmid":"18344491","id":"PMC_18344491","title":"Identification of novel genes including Dermo-1, a marker of dermal differentiation, expressed in trout somitic external cells.","date":"2008","source":"The Journal of experimental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18344491","citation_count":20,"is_preprint":false},{"pmid":"26019273","id":"PMC_26019273","title":"Twist1 and Twist2 Contribute to Cytokine Downregulation following Chronic NOD2 Stimulation of Human Macrophages through the Coordinated Regulation of Transcriptional Repressors and Activators.","date":"2015","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/26019273","citation_count":19,"is_preprint":false},{"pmid":"34044016","id":"PMC_34044016","title":"TWIST2 inhibits EMT and induces oxidative stress in lung cancer cells by regulating the FGF21-mediated AMPK/mTOR pathway.","date":"2021","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/34044016","citation_count":18,"is_preprint":false},{"pmid":"21801849","id":"PMC_21801849","title":"Nonsense mutations of the bHLH transcription factor TWIST2 found in Setleis Syndrome patients cause dysregulation of periostin.","date":"2011","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21801849","citation_count":18,"is_preprint":false},{"pmid":"30779884","id":"PMC_30779884","title":"Role of epithelial-mesenchymal transition regulated by twist basic helix-loop-helix transcription factor 2 (Twist2) in embryo implantation in mice.","date":"2019","source":"Reproduction, fertility, and development","url":"https://pubmed.ncbi.nlm.nih.gov/30779884","citation_count":17,"is_preprint":false},{"pmid":"31028123","id":"PMC_31028123","title":"Twist1 and Twist2 Induce Human Macrophage Memory upon Chronic Innate Receptor Treatment by HDAC-Mediated Deacetylation of Cytokine Promoters.","date":"2019","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/31028123","citation_count":16,"is_preprint":false},{"pmid":"24944676","id":"PMC_24944676","title":"Twist2 contributes to cisplatin-resistance of ovarian cancer through the AKT/GSK-3β signaling pathway.","date":"2014","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/24944676","citation_count":16,"is_preprint":false},{"pmid":"25420506","id":"PMC_25420506","title":"The indicative function of Twist2 and E-cadherin in HPV oncogene-induced epithelial-mesenchymal transition of cervical cancer cells.","date":"2014","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/25420506","citation_count":16,"is_preprint":false},{"pmid":"35962139","id":"PMC_35962139","title":"Nicotinamide mononucleotide ameliorates adriamycin-induced renal damage by epigenetically suppressing the NMN/NAD consumers mediated by Twist2.","date":"2022","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/35962139","citation_count":15,"is_preprint":false},{"pmid":"30127033","id":"PMC_30127033","title":"Identification of a multipotent Twist2-expressing cell population in the adult heart.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30127033","citation_count":14,"is_preprint":false},{"pmid":"28658273","id":"PMC_28658273","title":"A structural variant in the 5'-flanking region of the TWIST2 gene affects melanocyte development in belted cattle.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28658273","citation_count":13,"is_preprint":false},{"pmid":"37115930","id":"PMC_37115930","title":"TWIST2-mediated chromatin remodeling promotes fusion-negative rhabdomyosarcoma.","date":"2023","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/37115930","citation_count":12,"is_preprint":false},{"pmid":"36810156","id":"PMC_36810156","title":"Kinetic networks identify TWIST2 as a key regulatory node in adipogenesis.","date":"2023","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/36810156","citation_count":12,"is_preprint":false},{"pmid":"34232948","id":"PMC_34232948","title":"Prostaglandin D2 synthase/prostaglandin D2/TWIST2 signaling inhibits breast cancer proliferation.","date":"2021","source":"Anti-cancer drugs","url":"https://pubmed.ncbi.nlm.nih.gov/34232948","citation_count":12,"is_preprint":false},{"pmid":"28722198","id":"PMC_28722198","title":"Male germline recombination of a conditional allele by the widely used Dermo1-cre (Twist2-cre) transgene.","date":"2017","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/28722198","citation_count":12,"is_preprint":false},{"pmid":"22884497","id":"PMC_22884497","title":"Twist2 contributes to termination of limb bud outgrowth and patterning through direct regulation of Grem1.","date":"2012","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/22884497","citation_count":12,"is_preprint":false},{"pmid":"25410422","id":"PMC_25410422","title":"Setleis syndrome: clinical, molecular and structural studies of the first TWIST2 missense mutation.","date":"2014","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25410422","citation_count":12,"is_preprint":false},{"pmid":"27391798","id":"PMC_27391798","title":"Expression of Twist2 is controlled by T-cell receptor signaling and determines the survival and death of thymocytes.","date":"2016","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/27391798","citation_count":11,"is_preprint":false},{"pmid":"33994357","id":"PMC_33994357","title":"Zebrafish twist2/dermo1 regulates scale shape and scale organization during skin development and regeneration.","date":"2021","source":"Cells & development","url":"https://pubmed.ncbi.nlm.nih.gov/33994357","citation_count":10,"is_preprint":false},{"pmid":"20574024","id":"PMC_20574024","title":"Twist2: role in corneal stromal keratocyte proliferation and corneal thickness.","date":"2010","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/20574024","citation_count":10,"is_preprint":false},{"pmid":"33949284","id":"PMC_33949284","title":"MIR205 host gene (MIR205HG) drives osteosarcoma metastasis via regulating the microRNA 2114-3p (miR-2114-3p)/twist family bHLH transcription factor 2 (TWIST2) axis.","date":"2021","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/33949284","citation_count":10,"is_preprint":false},{"pmid":"16470627","id":"PMC_16470627","title":"Analysis of scleraxis and dermo-1 genes in a regenerating limb of Xenopus laevis.","date":"2006","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/16470627","citation_count":10,"is_preprint":false},{"pmid":"24127007","id":"PMC_24127007","title":"A novel frameshift mutation in TWIST2 gene causing Setleis syndrome.","date":"2013","source":"Indian journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/24127007","citation_count":10,"is_preprint":false},{"pmid":"29424894","id":"PMC_29424894","title":"Twist2 and CD24 expression alters renal microenvironment in obesity associated kidney cancer.","date":"2018","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29424894","citation_count":9,"is_preprint":false},{"pmid":"23946798","id":"PMC_23946798","title":"Twist2 promotes ovarian cancer cell survival through activation of Akt.","date":"2013","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/23946798","citation_count":9,"is_preprint":false},{"pmid":"31433071","id":"PMC_31433071","title":"TWIST2: A new candidate tumor suppressor in prostate cancer.","date":"2019","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/31433071","citation_count":8,"is_preprint":false},{"pmid":"25048179","id":"PMC_25048179","title":"Hyperthermia inhibited the migration of tongue squamous cell carcinoma through TWIST2.","date":"2014","source":"Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25048179","citation_count":8,"is_preprint":false},{"pmid":"32424141","id":"PMC_32424141","title":"Twist2 promotes CD8+ T-cell differentiation by repressing ThPOK expression.","date":"2020","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/32424141","citation_count":7,"is_preprint":false},{"pmid":"41213962","id":"PMC_41213962","title":"HOXA10-TWIST2 antagonism drives partial epithelial-to-mesenchymal transition for embryo implantation.","date":"2025","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/41213962","citation_count":7,"is_preprint":false},{"pmid":"33879188","id":"PMC_33879188","title":"TWIST2 and the PPAR signaling pathway are important in the progression of nonalcoholic steatohepatitis.","date":"2021","source":"Lipids in health and disease","url":"https://pubmed.ncbi.nlm.nih.gov/33879188","citation_count":7,"is_preprint":false},{"pmid":"33139779","id":"PMC_33139779","title":"Twist2 is NFkB-responsive when p120-catenin is inactivated and EGFR is overexpressed in esophageal keratinocytes.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33139779","citation_count":7,"is_preprint":false},{"pmid":"24005898","id":"PMC_24005898","title":"The effects of Twist-2 on liver endotoxin tolerance induced by a low dose of lipopolysaccharide.","date":"2014","source":"Inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/24005898","citation_count":7,"is_preprint":false},{"pmid":"35340228","id":"PMC_35340228","title":"Expression of Dickkopf-1 and Twist2 in Cervical Squamous Cell Carcinoma and Their Correlation with Vasculogenic Mimicry.","date":"2022","source":"Journal of healthcare engineering","url":"https://pubmed.ncbi.nlm.nih.gov/35340228","citation_count":5,"is_preprint":false},{"pmid":"40749657","id":"PMC_40749657","title":"Decabromodiphenyl ethane induces intrauterine growth restriction by suppressing placental angiogenesis via TWIST2/NAT10-mediated ac4C-dependent TGF-β1 mRNA stabilization.","date":"2025","source":"Journal of hazardous materials","url":"https://pubmed.ncbi.nlm.nih.gov/40749657","citation_count":5,"is_preprint":false},{"pmid":"21109964","id":"PMC_21109964","title":"Differential methylation of CpG islands within the dermo1 gene promoter in several cancer cell lines.","date":"2011","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/21109964","citation_count":5,"is_preprint":false},{"pmid":"36374263","id":"PMC_36374263","title":"Twist2-expressing cells reside in human skeletal muscle and are responsive to aging and resistance exercise training.","date":"2022","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/36374263","citation_count":5,"is_preprint":false},{"pmid":"35700708","id":"PMC_35700708","title":"Twist2 Reduced NLRP3-Induced Inflammation of Infantile Pneumonia via Regulation of Mitochondrial Permeability Transition by FOXO1.","date":"2022","source":"International archives of allergy and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35700708","citation_count":5,"is_preprint":false},{"pmid":"36262967","id":"PMC_36262967","title":"The Elevated Circ_0067835 Could Accelerate Cell Proliferation and Metastasis via miR-1236-3p/Twist2 Axis in Hepatocellular Carcinoma.","date":"2022","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/36262967","citation_count":5,"is_preprint":false},{"pmid":"23689353","id":"PMC_23689353","title":"Aneuploidy facilitates oncogenic transformation via specific genetic alterations, including Twist2 upregulation.","date":"2013","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/23689353","citation_count":5,"is_preprint":false},{"pmid":"28208580","id":"PMC_28208580","title":"Twist2 Is Upregulated in Early Stages of Repair Following Acute Kidney Injury.","date":"2017","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28208580","citation_count":5,"is_preprint":false},{"pmid":"31293641","id":"PMC_31293641","title":"Asymmetric Division Gene Neurl2 Mediates Twist2 Regulation of Self-Renewal of Mouse Lewis Lung Cancer Stem Cells.","date":"2019","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31293641","citation_count":5,"is_preprint":false},{"pmid":"29329175","id":"PMC_29329175","title":"Clinical Description, Molecular Analysis of TWIST2 Gene, and Surgical Treatment in a Patient With Barber-Say Syndrome.","date":"2018","source":"Ophthalmic plastic and reconstructive surgery","url":"https://pubmed.ncbi.nlm.nih.gov/29329175","citation_count":5,"is_preprint":false},{"pmid":"40222483","id":"PMC_40222483","title":"HDAC4 super-enhancer drives CEBPB-mediated TWIST2 transcription to promote chemoresistance in LUAD.","date":"2025","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/40222483","citation_count":4,"is_preprint":false},{"pmid":"25608809","id":"PMC_25608809","title":"Biological function and molecular mechanism of Twist2.","date":"2015","source":"Yi chuan = Hereditas","url":"https://pubmed.ncbi.nlm.nih.gov/25608809","citation_count":4,"is_preprint":false},{"pmid":"38740788","id":"PMC_38740788","title":"Twist2 contributes to skin regeneration and hair follicle formation in mouse fetuses.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/38740788","citation_count":4,"is_preprint":false},{"pmid":"29983794","id":"PMC_29983794","title":"Upregulation of Twist2 in Non-Muscle Invasive Urothelial Carcinoma of the Bladder Correlate with Response to Treatment and Progression.","date":"2018","source":"Open access Macedonian journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29983794","citation_count":4,"is_preprint":false},{"pmid":"20025523","id":"PMC_20025523","title":"Enhanced generation of myeloid lineages in hematopoietic differentiation from embryonic stem cells by silencing transcriptional repressor Twist-2.","date":"2009","source":"Cloning and stem cells","url":"https://pubmed.ncbi.nlm.nih.gov/20025523","citation_count":4,"is_preprint":false},{"pmid":"33669496","id":"PMC_33669496","title":"Expression Profiling Identifies TWIST2 Target Genes in Setleis Syndrome Patient Fibroblast and Lymphoblast Cells.","date":"2021","source":"International journal of environmental research and public health","url":"https://pubmed.ncbi.nlm.nih.gov/33669496","citation_count":3,"is_preprint":false},{"pmid":"39918659","id":"PMC_39918659","title":"Twist2 knockdown alleviates renal ischemia-reperfusion injury by maintaining mitochondrial function and enhancing mitophagy through Bnip3.","date":"2025","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/39918659","citation_count":3,"is_preprint":false},{"pmid":"35162374","id":"PMC_35162374","title":"Single Nucleotide Polymorphism of TWIST2 May Be a Modifier for the Association between High-Density Lipoprotein Cholesterol and Blood Lead (Pb) Level.","date":"2022","source":"International journal of environmental research and public health","url":"https://pubmed.ncbi.nlm.nih.gov/35162374","citation_count":3,"is_preprint":false},{"pmid":"28680619","id":"PMC_28680619","title":"Barber-say syndrome: a confirmed case of TWIST2 gene mutation.","date":"2017","source":"Clinical case reports","url":"https://pubmed.ncbi.nlm.nih.gov/28680619","citation_count":3,"is_preprint":false},{"pmid":"29224276","id":"PMC_29224276","title":"[Expression and mechanism of Twist2 in glioma].","date":"2017","source":"Zhonghua bing li xue za zhi = Chinese journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/29224276","citation_count":2,"is_preprint":false},{"pmid":"34092176","id":"PMC_34092176","title":"Ocular adnexal phenotype and management of a patient with mosaic expression of a mutation in TWIST2.","date":"2021","source":"Orbit (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/34092176","citation_count":2,"is_preprint":false},{"pmid":"30157337","id":"PMC_30157337","title":"TWIST2 EXPRESSIONS IN PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE URINARY BLADDER SHOWED DOWN REGULATION CORRELATED WITH GOOD SURVIVAL AND LOW INCIDENCE OF DISTANT METASTASIS.","date":"2017","source":"Journal of the Egyptian Society of Parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/30157337","citation_count":2,"is_preprint":false},{"pmid":"37761873","id":"PMC_37761873","title":"Mechanisms of Regulation of the CHRDL1 Gene by the TWIST2 and ADD1/SREBP1c Transcription Factors.","date":"2023","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/37761873","citation_count":1,"is_preprint":false},{"pmid":"39444320","id":"PMC_39444320","title":"Comparative Analysis of Transcription Factors TWIST2, GATA3, and HES5 in Glioblastoma Multiforme : Evaluating Biomarker Potential and Therapeutic Targets Using in Silico Methods.","date":"2024","source":"Journal of Korean Neurosurgical Society","url":"https://pubmed.ncbi.nlm.nih.gov/39444320","citation_count":0,"is_preprint":false},{"pmid":"40282011","id":"PMC_40282011","title":"The Role of Twist2 in Myoblast Proliferation, Fusion, and Its Impact on Muscle Structure During the Growth of Chinese Perch (Siniperca chuatsi).","date":"2025","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/40282011","citation_count":0,"is_preprint":false},{"pmid":"37621628","id":"PMC_37621628","title":"Retracted: Expression of Dickkopf-1 and Twist2 in Cervical Squamous Cell Carcinoma and Their Correlation with Vasculogenic Mimicry.","date":"2023","source":"Journal of healthcare engineering","url":"https://pubmed.ncbi.nlm.nih.gov/37621628","citation_count":0,"is_preprint":false},{"pmid":"41714028","id":"PMC_41714028","title":"Lineage tracing of Twist2-expressing cells in mouse taste buds.","date":"2025","source":"Journal of oral biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/41714028","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49333,"output_tokens":8299,"usd":0.136242,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18104,"output_tokens":7130,"usd":0.134385,"stage2_stop_reason":"end_turn"},"total_usd":0.270627,"stage1_batch_id":"msgbatch_017qqVz33Ga63SCDwzb35XPb","stage2_batch_id":"msgbatch_01Scr2Ei9x4HJMiRGxwrmvLK","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"Dermo-1 (TWIST2) is a bHLH protein that dimerizes with the ubiquitous bHLH protein E12 to bind E-box consensus sequences (CANNTG), but lacks detectable transcriptional activation activity; instead it represses transcriptional activity of myogenic bHLH proteins.\",\n      \"method\": \"Yeast two-hybrid screening, electrophoretic mobility shift assay (EMSA), transcriptional reporter assays\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro binding assays, reporter assays, and yeast two-hybrid reconstitution in the foundational paper; replicated in subsequent work\",\n      \"pmids\": [\"7589808\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"TWIST2 (Dermo-1) represses MyoD-mediated transactivation through its HLH and C-terminal domains, directly interacts with MEF2 via its N- and C-terminal domains (but not the bHLH domain) to selectively repress the MEF2 transactivation domain, and recruits histone deacetylase activity to mediate chromatin-level repression (trichostatin A treatment reduces repression activity).\",\n      \"method\": \"Deletion mutagenesis of Dermo-1, transcriptional reporter assays, co-immunoprecipitation/direct protein interaction assays, HDAC inhibitor treatment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (mutagenesis, reporter assays, protein interaction, pharmacological inhibition) in a single rigorous study\",\n      \"pmids\": [\"11809751\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"TWIST2 physically interacts with ADD1/SREBP1c (identified by yeast two-hybrid and confirmed by co-immunoprecipitation) and represses ADD1/SREBP1c transcriptional activity primarily by reducing its DNA binding to target sequences; this repression is partially dependent on HDAC activity.\",\n      \"method\": \"Yeast two-hybrid with adipocyte cDNA library, co-immunoprecipitation, transcriptional reporter assays, HDAC inhibitor treatment\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — yeast two-hybrid plus co-immunoprecipitation plus reporter assays plus pharmacological dissection, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"14654692\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TWIST2 inhibits the proliferation and differentiation of granulocyte-macrophage progenitors by interacting with and inhibiting the transcription factors Runx1 and C/EBPα; it also activates c-Maf transcription to promote IL-10 production while inhibiting IL-12 and IFNγ production; Twist2-deficient mice show marked increases in macrophages, neutrophils, and basophils.\",\n      \"method\": \"Twist-2 knockout mice, mechanistic studies with protein-protein interaction assays, gene expression analysis, cytokine measurements\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function (knockout mice) with defined cellular phenotype plus mechanistic protein interaction studies\",\n      \"pmids\": [\"19090621\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Homozygous nonsense mutations in TWIST2 (c.324C>T [p.Q65X] and c.486C>T [p.Q119X]) cause Setleis syndrome; the expressed truncated mutant proteins are unstable and fail to bind DNA normally as shown by electrophoretic mobility shift assays and immunoblot analysis.\",\n      \"method\": \"Homozygosity mapping, gene sequencing, EMSA, immunoblot analysis of mutant proteins\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct biochemical characterization of mutant proteins by EMSA and immunoblot, corroborated by human genetics\",\n      \"pmids\": [\"20691403\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Canonical Wnt signaling/β-catenin is required and sufficient for Dermo1 (TWIST2) expression and dermal cell identity in the cranium; Dermo1 can be a direct transcriptional target of Wnt/β-catenin signaling in dermal precursors.\",\n      \"method\": \"Genetic fate mapping and conditional β-catenin gain/loss-of-function in mice, reporter gene assays\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis using conditional mouse knockouts and gain-of-function with defined phenotypic readout\",\n      \"pmids\": [\"20980404\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TWIST2 nonsense mutation Q119X maintains nuclear localization and homo/heterodimer formation with E12 and DNA binding, but fails to transactivate the periostin gene; the C-terminal domain of TWIST2 is required for proper transactivation and is associated with higher histone acetylation across the periostin 5'-regulatory region.\",\n      \"method\": \"Reporter gene assays with deletion constructs, EMSA, chromatin immunoprecipitation (ChIP), functional analysis in patient fibroblasts\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal methods (EMSA, reporter assays, ChIP) in patient-derived cells, single lab\",\n      \"pmids\": [\"21801849\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TWIST2 directly binds to the E-box region in the CD24 promoter to activate CD24 expression; Twist2-mediated promotion of liver cancer stem-like cell self-renewal operates through a CD24-STAT3-Nanog pathway.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) of CD24 promoter, stable Twist2 overexpression and knockdown in HCC cells, in vitro/in vivo functional assays\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP assay plus functional rescue experiments, single lab\",\n      \"pmids\": [\"24193512\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"LPS promotes PDCD4 degradation via PI3K/mTOR pathway, releasing TWIST2 from a PDCD4-TWIST2 complex; free TWIST2 then binds the c-Maf promoter to induce c-Maf mRNA and downstream IL-10 production in macrophages.\",\n      \"method\": \"Co-immunoprecipitation of PDCD4-TWIST2 complex, promoter binding assays, PI3K/mTOR inhibitor treatment, macrophage stimulation with LPS\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-immunoprecipitation plus promoter-binding assays plus pharmacological dissection, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"24982420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TWIST2 directly activates p21 transcription (requiring intact HLH domain) in human hematopoietic cells; overexpression inhibits AML cell growth partially through p21 induction, while hypermethylation of the TWIST2 promoter silences both TWIST2 and p21 in AML patients.\",\n      \"method\": \"Overexpression and knockdown experiments, cell cycle analysis, promoter methylation analysis (pyrosequencing/COBRA), gene expression microarray\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss/gain-of-function with mechanistic follow-up including domain requirements, single lab\",\n      \"pmids\": [\"25088197\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Recurrent de novo missense mutations in the basic domain of TWIST2 (at residue Glu75) cause Ablepharon macrostomia syndrome (Lys substitution) or Barber-Say syndrome (Gln or Ala substitution); these mutations alter the DNA-binding pattern of TWIST2 in HeLa cells.\",\n      \"method\": \"Whole exome sequencing, candidate gene sequencing, functional validation of Flag-TWIST2 DNA binding in HeLa cells, zebrafish expression studies\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — functional DNA-binding assays in cells, multiple independent families, genotype-phenotype correlation validated in zebrafish\",\n      \"pmids\": [\"26119818\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"TWIST1 and TWIST2 bind to cytokine promoters during chronic NOD2 stimulation; they cooperate to enhance binding of c-Maf and Bmi1 to cytokine promoters while decreasing binding of transcriptional activators (ATF4, C/EBPα, Runx1, Runx2), thereby mediating cytokine downregulation in human macrophages.\",\n      \"method\": \"Chromatin immunoprecipitation of cytokine promoters, siRNA knockdown in primary human macrophages, rescue experiments with c-Maf and Bmi1 restoration\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus siRNA knockdown with rescue in primary human cells, single lab\",\n      \"pmids\": [\"26019273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TWIST2 directly binds the E-cadherin promoter at the -714 bp region (but not the -295 bp region) to repress E-cadherin transcription; HIF-2α promotes EMT in pancreatic cancer by regulating Twist2 binding to the E-cadherin promoter.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) assay, Western blot, siRNA knockdown\",\n      \"journal\": \"Journal of experimental & clinical cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP assay demonstrating direct promoter binding, single lab\",\n      \"pmids\": [\"26842802\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"TWIST2 transcription factor directly binds the promoter of miR-221-3p to promote its expression; miR-221-3p then targets THBS2 mRNA to suppress its expression, forming a TWIST2→miR-221-3p→THBS2 axis promoting cervical cancer lymphatic metastasis.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), luciferase reporter assays, miR-221-3p overexpression/inhibition in vitro and in vivo\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus reporter assays confirming direct promoter binding, single lab\",\n      \"pmids\": [\"29242498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Lineage tracing reveals Twist2-expressing progenitor cells reside outside the basal lamina of adult skeletal muscle, are molecularly and anatomically distinct from Pax7+ satellite cells, contribute specifically to type IIb/x myofibres, and their genetic ablation causes wasting of type IIb myofibres; Tw2 expression maintains progenitors in an undifferentiated state.\",\n      \"method\": \"Tamoxifen-inducible lineage tracing (Twist2-CreERT2 x reporter mice), genetic ablation (diphtheria toxin), in vitro myogenesis assays, immunofluorescence, electron microscopy\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic lineage tracing plus genetic ablation with defined fiber-type-specific phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"28218909\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"De novo mutations at TWIST2 Glu117 (equivalent residue to TWIST1 Glu117) in the basic DNA-binding domain act via a predominantly dominant-negative mechanism as demonstrated by allelic series in C. elegans hlh-8, showing graded severity in gene expression and cellular phenotype.\",\n      \"method\": \"Targeted mutagenesis of C. elegans hlh-8 allelic series, gene expression analysis, cellular phenotype assessment\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic allelic series mutagenesis in C. elegans with functional readouts; ortholog model\",\n      \"pmids\": [\"28369379\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TWIST2 competes with MyoD at shared DNA motifs genome-wide (revealed by ChIP-seq) to direct global gene transcription and repression of the myogenic program; TWIST2 shapes the epigenetic landscape by driving chromatin opening at oncogenic loci and chromatin closing at myogenic loci, thereby redirecting MyoD binding from myogenic genes toward oncogenic/metabolic/growth genes in rhabdomyosarcoma.\",\n      \"method\": \"Inducible Twist2 expression system, genome-wide ChIP-seq, RNA-seq, ATAC-seq, knockdown in RMS cells\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — genome-wide ChIP-seq plus ATAC-seq plus RNA-seq in inducible system, multiple orthogonal methods\",\n      \"pmids\": [\"30975722\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Chronic NOD2 stimulation upregulates Twist1/Twist2, which bind to promoters of HDAC1 and HDAC3 to induce their expression; HDAC1 and HDAC3 then mediate histone deacetylation at cytokine promoters, resulting in cytokine downregulation (macrophage memory/tolerance).\",\n      \"method\": \"Chromatin immunoprecipitation of HDAC1/HDAC3 promoters, siRNA knockdown in primary human macrophages, histone acetylation assays, rescue experiments\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus knockdown plus rescue experiments in primary human cells, single lab\",\n      \"pmids\": [\"31028123\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In positively selected thymocytes, TWIST2 expression is induced via the Ca2+-Calcineurin-NFATc3 pathway; stronger TCR signals activating the JNK pathway abolish NFATc3-dependent Twist2 induction. Twist2 determines thymocyte sensitivity to TCR-mediated apoptosis by repressing Nur77 expression; mechanistically, Twist2 retains HDAC7 in the nucleus and recruits it to the Nur77 promoter.\",\n      \"method\": \"Twist2-deficient and transgenic mice, ChIP of Nur77 promoter, pharmacological pathway inhibition (calcineurin, JNK inhibitors), apoptosis assays\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic mouse models (KO and transgenic) plus ChIP plus pharmacological pathway dissection with defined phenotype\",\n      \"pmids\": [\"27391798\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"During CD8 T-cell lineage differentiation, TWIST2 interacts with Runx3 and the complex binds to the silencer region of the ThPOK locus to block ThPOK expression, thereby promoting CD8+ thymocyte differentiation.\",\n      \"method\": \"Twist2-deficient mice, MHC class II-/- and TCR transgenic mouse models, protein-protein interaction assays (Twist2-Runx3), chromatin binding assays at ThPOK silencer\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic mouse models plus direct demonstration of Twist2-Runx3 interaction at ThPOK silencer\",\n      \"pmids\": [\"32424141\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ZNF451, a SUMO2/3-specific E3 ligase, directly binds TWIST2 and SUMOylates it at K129, thereby blocking ubiquitin-proteasome-dependent degradation and stabilizing TWIST2 protein to promote EMT.\",\n      \"method\": \"Co-immunoprecipitation, SUMOylation assays, site-directed mutagenesis (K129), ZNF451 overexpression/depletion in mammary epithelial cells, Western blot\",\n      \"journal\": \"American journal of cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical SUMOylation assay with identified site plus functional consequences, single lab\",\n      \"pmids\": [\"33791162\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TWIST2 drives postnatal maturation of papillary dermal fibroblasts through extensive chromatin remodeling; genetic deletion of Twist2 in dermal fibroblasts delays the postnatal loss of regenerative ability, which is characterized by decreased H3K27ac levels and decreased chromatin accessibility.\",\n      \"method\": \"Single-cell transcriptomics, ATAC-seq, ChIP-seq, genetic Twist2 deletion in dermal fibroblasts, HDAC inhibitor treatment\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO plus ATAC-seq plus ChIP-seq with multiple orthogonal genomic and functional readouts\",\n      \"pmids\": [\"35584664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TWIST2 controls H3K27 acetylation at distal enhancers in fusion-negative rhabdomyosarcoma by interacting with chromatin remodelers SMARCA4 and CHD3, activating growth-related target genes and repressing myogenesis-related target genes; TWIST2 knockdown enables FN-RMS cells to exit the cell cycle and undergo terminal myogenesis.\",\n      \"method\": \"Co-immunoprecipitation of TWIST2 with SMARCA4 and CHD3, ChIP-seq for H3K27ac, RNA-seq, shRNA knockdown, mouse xenograft model\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP identifying SMARCA4/CHD3 partners plus ChIP-seq plus RNA-seq plus in vivo xenograft, multiple orthogonal methods\",\n      \"pmids\": [\"37115930\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TWIST2 acts as a negative regulator of adipocyte differentiation in 3T3-L1 and primary preadipocytes; Twist2 knockout mice have compromised lipid storage in subcutaneous and brown adipose tissue.\",\n      \"method\": \"Kinetic ATAC-seq and PRO-seq (nascent transcription) network analysis, Twist2 knockout mice, adipocyte differentiation assays\",\n      \"journal\": \"Genome research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO mice with tissue phenotype plus temporal chromatin/transcription data, single lab\",\n      \"pmids\": [\"36810156\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TWIST2 overexpression in chick limb bud (RCAS-mediated) causes hypoplastic limb phenotypes through premature termination of limb outgrowth; TWIST2 directly represses Grem1 expression via a regulatory element downstream of the Grem1 open reading frame, thereby downregulating the Shh/Grem1/Fgf autoregulatory loop; co-expression of Grem1 rescues the Twist2 overexpression phenotype.\",\n      \"method\": \"RCAS retroviral misexpression in chick limb, in situ hybridization, direct regulatory element analysis (reporter/binding assays), genetic rescue with Grem1 co-expression\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function with genetic rescue plus direct regulatory element analysis, single lab\",\n      \"pmids\": [\"22884497\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The first TWIST2 missense mutation (p.Leu109Pro) causing Setleis syndrome is predicted by in silico modeling to increase unfavorable force field energy; the proline substitution is located near the dimer interface and is predicted to hinder dimer formation, thereby preventing TWIST2 from binding target genes.\",\n      \"method\": \"Homozygosity mapping, gene sequencing, in silico structural modeling on crystallographically generated dimer\",\n      \"journal\": \"Clinical genetics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — structural inference is purely in silico/computational; no experimental biochemical validation of dimerization defect\",\n      \"pmids\": [\"25410422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"KLF15 directly interacts with the Twist2 promoter to activate TWIST2 expression; SREBP1c and FOXO1 repress TWIST2 expression; TWIST2 overexpression inhibits NF-κB nuclear translocation and binding to the FGF21 promoter, thereby de-repressing FGF21 expression to ameliorate hepatic steatosis.\",\n      \"method\": \"ChIP assays on Twist2 and FGF21 promoters, TWIST2 overexpression and knockdown in hepatocytes, in vivo mouse knockdown model\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP assays plus in vivo and in vitro functional experiments, single lab\",\n      \"pmids\": [\"31648561\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TWIST2 and ADD1/SREBP1c compete for binding to the same E-box in the CHRDL1 gene upstream region; TWIST2 (but not TWIST2-Q119X mutant) blocks ADD1/SREBP1c-mediated activation of CHRDL1, while the Q119X mutant may form an inactive complex with ADD1/SREBP1c that allows other activators to increase CHRDL1 expression.\",\n      \"method\": \"EMSA (homo/heterodimer binding assays), EMSA competition assays, luciferase reporter assays, patient fibroblast/lymphoblast expression analysis\",\n      \"journal\": \"Genes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — EMSA and reporter assays with mutant and wild-type proteins, single lab\",\n      \"pmids\": [\"37761873\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"TWIST2 directly inhibits Bnip3 transcriptional activity by binding the Bnip3 promoter; TWIST2 knockdown alleviates renal ischemia-reperfusion injury by improving mitochondrial function and enhancing mitophagy through de-repression of Bnip3.\",\n      \"method\": \"RNAi knockdown in mice and HK-2 cells, promoter binding assay (luciferase/ChIP implied), mitochondrial function assays, autophagy markers, electron microscopy\",\n      \"journal\": \"Human cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KD in vivo and in vitro with mechanistic rescue experiments, single lab\",\n      \"pmids\": [\"39918659\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"HOXA10 directly represses TWIST2 in endometrial luminal epithelium; HOXA10 loss de-represses TWIST2 to induce partial EMT and increased cell motility; TWIST2 knockdown restores epithelial identity and impairs embryo implantation; CUT&RUN and transcriptomic profiling confirm HOXA10 directly activates epithelial gene networks and represses mesenchymal programs including TWIST2.\",\n      \"method\": \"CUT&RUN, transcriptomic profiling, siRNA knockdown of HOXA10 and TWIST2 in human endometrial cells, in vivo mouse implantation model\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CUT&RUN plus transcriptomics plus in vivo functional assays, single lab\",\n      \"pmids\": [\"41213962\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TWIST2 promotes survival of ovarian cancer cells under hypoxic conditions through activation of Akt (PI3K-Akt pathway); Twist2-overexpressing cells show increased Akt phosphorylation under DFO-induced hypoxic stress, reducing apoptosis.\",\n      \"method\": \"Stable Twist2 overexpression in SKOV-3 cells, DFO-induced hypoxia simulation, flow cytometry for apoptosis, Western blot for Akt phosphorylation\",\n      \"journal\": \"Oncology letters\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single-method overexpression with Western blot readout, no direct mechanistic dissection of how TWIST2 activates Akt\",\n      \"pmids\": [\"23946798\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TWIST2 downregulates CD7 gene promoter activity through its C-terminal domain, and recruits histone deacetylase activity (sensitive to TSA and sodium butyrate); ectopic Twist2 expression in Jurkat cells reduces galectin-1-induced apoptosis.\",\n      \"method\": \"Promoter reporter assays with C-terminal deletion mutants, HDAC inhibitor treatment (TSA, sodium butyrate), ectopic Twist2 expression, apoptosis assays\",\n      \"journal\": \"Molecules and cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reporter assays with deletion mutagenesis plus pharmacological HDAC inhibition, single lab\",\n      \"pmids\": [\"19937140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TWIST2 downregulation in Twist2-siRNA-treated ovarian cancer cells sensitizes them to cisplatin; conversely, TWIST2 overexpression promotes cisplatin resistance through the AKT/GSK-3β signaling pathway.\",\n      \"method\": \"Plasmid overexpression and siRNA knockdown in OV2008/C13K cells, cell viability assays, apoptosis analysis, Western blot for pAKT/pGSK-3β\",\n      \"journal\": \"Oncology letters\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single-method overexpression/knockdown with pathway marker readout, no direct mechanistic link established\",\n      \"pmids\": [\"24944676\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A structural variant (quadruplication of a 6 kb non-coding sequence ~16 kb upstream of TWIST2) causes aberrant TWIST2 expression during neural crest development; ectopic expression of bovine TWIST2 in neural crest in transgenic zebrafish leads to decreased melanocyte numbers, implicating TWIST2 in regulating pigmentation.\",\n      \"method\": \"Whole genome sequencing, copy number variant analysis, transgenic zebrafish with ectopic TWIST2 expression in neural crest\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional transgenic zebrafish experiment with defined phenotypic readout, single lab\",\n      \"pmids\": [\"28658273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In osteoblastic cells, Twist2 haploinsufficiency reduces Fgf2 and Fgfr1-4 expression; both Twist1 and Twist2 stimulate 4.9 kb Fgfr2 promoter activity in the presence of the Twist binding partner E12, indicating TWIST2 directly regulates FGF signaling components.\",\n      \"method\": \"Conditional haploinsufficient mouse model (Twist1f/+;Twist2Cre/+), dual luciferase reporter assays with E12, in situ hybridization, real-time PCR\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic mouse model plus reporter assay in presence of E12 dimerization partner, single lab\",\n      \"pmids\": [\"24971743\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"TWIST2 (DERMO1/bHLHa39) is a basic helix-loop-helix transcription factor that forms homodimers and E12 heterodimers to bind E-box sequences, functioning primarily as a transcriptional repressor by recruiting HDAC activity (via HDAC1/3/7) and competing with activators (MyoD, MEF2, C/EBPα, Runx1, ADD1/SREBP1c) at shared DNA motifs; it regulates mesenchymal cell lineage decisions (dermis, bone, muscle, myeloid, lymphoid), controls chromatin accessibility at myogenic vs. oncogenic loci through interactions with SMARCA4 and CHD3, modulates inflammatory responses in macrophages through c-Maf/IL-10 and PDCD4-dependent mechanisms, is stabilized post-translationally by ZNF451-mediated SUMOylation at K129, and is required for type IIb/x skeletal muscle fibre maintenance, with loss-of-function mutations causing Setleis, Ablepharon macrostomia, and Barber-Say syndromes.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"TWIST2 (Dermo-1) is a basic helix-loop-helix transcription factor that dimerizes with the ubiquitous bHLH protein E12 to bind E-box (CANNTG) motifs and acts predominantly as a transcriptional repressor that controls mesenchymal lineage decisions across dermis, muscle, bone, and hematopoietic compartments [#0, #34]. Lacking intrinsic activation activity, it represses target loci by recruiting histone deacetylase activity (HDAC-inhibitor-sensitive) and by competing with or directly antagonizing lineage-specifying activators including the myogenic factors MyoD and MEF2, ADD1/SREBP1c, Runx1, and C/EBPα at shared DNA elements [#1, #2, #3, #27]. At genome scale TWIST2 shapes the epigenetic landscape: it competes with MyoD across the genome to close myogenic loci and open growth/oncogenic loci, and it controls H3K27 acetylation at distal enhancers through physical interaction with the chromatin remodelers SMARCA4 and CHD3, thereby sustaining proliferation and blocking terminal myogenesis in fusion-negative rhabdomyosarcoma [#16, #22]. The same chromatin-remodeling activity drives postnatal maturation of dermal fibroblasts by reorganizing accessibility and H3K27ac [#21]. In adult skeletal muscle, Twist2 marks a satellite-cell-independent progenitor population that maintains type IIb/x myofibres and holds these progenitors in an undifferentiated state [#14]. TWIST2 also operates as a context-dependent activator and immune modulator, inducing c-Maf to promote IL-10 while restraining inflammatory cytokines in macrophages—a function gated by release from a PDCD4–TWIST2 complex—and shaping thymocyte selection and CD8 lineage commitment through repression of Nur77 (via nuclear retention of HDAC7) and ThPOK (via a Runx3 complex) [#3, #8, #18, #19]. TWIST2 protein stability is regulated by ZNF451-mediated SUMOylation at K129, which blocks proteasomal degradation [#20]. Loss-of-function nonsense mutations cause Setleis syndrome, while recurrent de novo missense mutations in the basic DNA-binding domain (residue Glu75) cause Ablepharon macrostomia and Barber-Say syndromes by altering DNA-binding specificity [#4, #10].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established the founding biochemical identity of TWIST2 as an E12-dimerizing E-box-binding bHLH factor that represses rather than activates, defining its core molecular mode of action.\",\n      \"evidence\": \"Yeast two-hybrid, EMSA, and reporter assays defining E12 dimerization and repression of myogenic bHLH proteins\",\n      \"pmids\": [\"7589808\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct target genes in vivo not yet identified\", \"Mechanism of repression (cofactor recruitment) not yet defined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Resolved how TWIST2 represses the myogenic program by mapping the domains that bind MyoD and MEF2 and demonstrating HDAC-dependent chromatin-level repression.\",\n      \"evidence\": \"Deletion mutagenesis, co-IP, reporter assays, and TSA treatment in transcription assays\",\n      \"pmids\": [\"11809751\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific HDAC isoforms not identified\", \"Endogenous target loci not mapped\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Extended TWIST2 repression to lipogenic transcription by showing it binds ADD1/SREBP1c and reduces its DNA binding, linking TWIST2 to adipocyte gene control.\",\n      \"evidence\": \"Yeast two-hybrid with adipocyte cDNA library, co-IP, reporter assays, HDAC inhibitor dissection\",\n      \"pmids\": [\"14654692\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance to adipogenesis not tested in this study\", \"Shared genomic targets not defined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstrated in vivo that TWIST2 restrains myeloid lineage output and reprograms cytokine balance, establishing a hematopoietic/immune regulatory role.\",\n      \"evidence\": \"Twist2-knockout mice with protein-interaction assays against Runx1/C/EBPα and cytokine measurements\",\n      \"pmids\": [\"19090621\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct genomic binding sites for c-Maf activation not mapped here\", \"How TWIST2 switches between repression and c-Maf activation unresolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Connected TWIST2 to human disease and to its upstream regulation, showing nonsense mutations cause Setleis syndrome and that Wnt/β-catenin drives Dermo1 expression in dermal identity.\",\n      \"evidence\": \"Homozygosity mapping with EMSA/immunoblot of mutant proteins; conditional β-catenin gain/loss mouse genetics\",\n      \"pmids\": [\"20691403\", \"20980404\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether truncations are pure loss-of-function or dominant-negative not resolved here\", \"Direct β-catenin binding element on Dermo1 not fully defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Distinguished the activation versus repression functions of TWIST2 domains by showing the disease mutant Q119X retains dimerization and DNA binding but fails to transactivate periostin.\",\n      \"evidence\": \"Reporter assays with deletion constructs, EMSA, ChIP, and patient fibroblast analysis\",\n      \"pmids\": [\"21801849\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Coactivators recruited by the C-terminal domain not identified\", \"Generality of activation function beyond periostin unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identified TWIST2 as a direct E-box activator of CD24 driving cancer stem-cell self-renewal, broadening its role to oncogenic transcriptional activation.\",\n      \"evidence\": \"ChIP of CD24 promoter with overexpression/knockdown and functional assays in HCC cells\",\n      \"pmids\": [\"24193512\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab ChIP without genome-wide validation\", \"Cofactor basis of activation vs repression context unresolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined post-transcriptional control of TWIST2 activity in macrophages, showing PDCD4 sequesters TWIST2 and LPS-driven PDCD4 degradation releases it to induce c-Maf/IL-10.\",\n      \"evidence\": \"Reciprocal co-IP of PDCD4-TWIST2, promoter binding assays, PI3K/mTOR inhibition, LPS stimulation\",\n      \"pmids\": [\"24982420\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of PDCD4-TWIST2 interaction unknown\", \"Whether sequestration generalizes beyond macrophages untested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Linked TWIST2 to cell-cycle control in hematopoietic malignancy by showing HLH-dependent direct activation of p21 and epigenetic silencing in AML.\",\n      \"evidence\": \"Overexpression/knockdown, cell-cycle analysis, promoter methylation analysis in AML samples\",\n      \"pmids\": [\"25088197\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct p21 promoter occupancy not shown by ChIP here\", \"Reconciliation of activator role with canonical repression unaddressed\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Established a second mutation class — recurrent de novo basic-domain missense at Glu75 — causing Ablepharon macrostomia and Barber-Say syndromes by altering DNA-binding pattern.\",\n      \"evidence\": \"Whole exome sequencing, Flag-TWIST2 DNA-binding assays in HeLa, zebrafish expression\",\n      \"pmids\": [\"26119818\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise mechanistic basis (gain vs altered specificity) only partly resolved\", \"Affected target gene set in disease tissue not defined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Expanded the macrophage repression mechanism by showing TWIST1/TWIST2 cooperatively remodel cytokine promoter occupancy, recruiting c-Maf/Bmi1 and displacing activators.\",\n      \"evidence\": \"ChIP of cytokine promoters with siRNA knockdown and c-Maf/Bmi1 rescue in primary human macrophages\",\n      \"pmids\": [\"26019273\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs cooperative binding contributions of TWIST2 alone unclear\", \"Single-lab ChIP without orthogonal genomic mapping\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrated TWIST2 represses E-cadherin via a defined promoter element downstream of hypoxic HIF-2α signaling, implicating it in EMT.\",\n      \"evidence\": \"ChIP mapping of E-cadherin promoter, Western blot, siRNA in pancreatic cancer cells\",\n      \"pmids\": [\"26842802\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cofactor/HDAC involvement at E-cadherin not dissected\", \"Direct HIF-2α-to-TWIST2 mechanistic link incomplete\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Placed TWIST2 in T-cell selection by showing NFATc3-driven induction and TWIST2-dependent repression of Nur77 via nuclear retention and recruitment of HDAC7.\",\n      \"evidence\": \"Twist2-KO and transgenic mice, ChIP of Nur77 promoter, calcineurin/JNK inhibition, apoptosis assays\",\n      \"pmids\": [\"27391798\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct HDAC7-TWIST2 binding interface not mapped\", \"Generalization to peripheral T cells untested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined a distinct adult muscle stem-cell function, identifying Twist2+ progenitors outside the basal lamina that maintain type IIb/x fibres and stay undifferentiated under Twist2 control.\",\n      \"evidence\": \"Inducible lineage tracing, diphtheria-toxin ablation, in vitro myogenesis, imaging in mice\",\n      \"pmids\": [\"28218909\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcriptional targets sustaining the undifferentiated state not mapped\", \"Relationship to satellite-cell signaling unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Clarified disease genetics by showing basic-domain mutations act through a predominantly dominant-negative mechanism via a graded allelic series in the ortholog.\",\n      \"evidence\": \"C. elegans hlh-8 allelic series mutagenesis with expression and phenotype readouts\",\n      \"pmids\": [\"28369379\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Dominant-negative mechanism inferred in ortholog, not human TWIST2 directly\", \"Molecular basis of interference with wild-type dimers not shown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Added metastasis-promoting activator function via a TWIST2→miR-221-3p→THBS2 axis and implicated non-coding upstream regulation in pigmentation phenotypes.\",\n      \"evidence\": \"ChIP and luciferase assays for miR-221-3p (cervical cancer); WGS/CNV with transgenic zebrafish neural-crest expression\",\n      \"pmids\": [\"29242498\", \"28658273\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab promoter assays\", \"Causal regulatory element architecture upstream of TWIST2 incompletely defined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Provided the genome-wide mechanism by which TWIST2 reprograms cell fate, competing with MyoD to redirect chromatin accessibility from myogenic to oncogenic loci.\",\n      \"evidence\": \"Inducible expression with ChIP-seq, ATAC-seq, RNA-seq, and knockdown in rhabdomyosarcoma cells\",\n      \"pmids\": [\"30975722\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Chromatin-remodeling cofactors mediating opening/closing not yet identified here\", \"Determinants of locus-specific opening vs closing unclear\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Extended the HDAC-repression theme by showing TWIST factors transcriptionally induce HDAC1/HDAC3 to deacetylate cytokine promoters during macrophage tolerance.\",\n      \"evidence\": \"ChIP of HDAC1/HDAC3 promoters, siRNA knockdown and rescue, histone acetylation assays in human macrophages\",\n      \"pmids\": [\"31028123\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"TWIST2-specific (vs TWIST1) contribution not isolated\", \"Single-lab ChIP without genome-wide confirmation\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified upstream transcriptional regulators of TWIST2 and a hepatic anti-inflammatory output via NF-κB inhibition and FGF21 de-repression.\",\n      \"evidence\": \"ChIP on Twist2 and FGF21 promoters with overexpression/knockdown and in vivo mouse knockdown\",\n      \"pmids\": [\"31648561\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of NF-κB nuclear translocation block not defined\", \"Single-lab data\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Revealed a partner-dependent lineage decision in which TWIST2-Runx3 complexes block ThPOK at its silencer to drive CD8 commitment.\",\n      \"evidence\": \"Multiple genetic mouse models with Twist2-Runx3 interaction and ThPOK silencer binding assays\",\n      \"pmids\": [\"32424141\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of TWIST2-Runx3 complex unknown\", \"Whether HDAC recruitment is involved untested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined post-translational stabilization of TWIST2 by ZNF451-mediated SUMOylation at K129 that blocks proteasomal degradation and promotes EMT.\",\n      \"evidence\": \"Co-IP, SUMOylation assays, K129 mutagenesis, ZNF451 manipulation in mammary epithelial cells\",\n      \"pmids\": [\"33791162\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab biochemistry\", \"In vivo relevance of K129 SUMOylation untested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Showed TWIST2 drives postnatal dermal fibroblast maturation through chromatin remodeling, with its loss preserving regenerative chromatin states.\",\n      \"evidence\": \"Single-cell transcriptomics, ATAC-seq, ChIP-seq, genetic Twist2 deletion, HDAC inhibitor treatment\",\n      \"pmids\": [\"35584664\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct cofactors mediating remodeling not identified here\", \"Reversibility of the maturation program unexplored\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified the chromatin-remodeling partners (SMARCA4, CHD3) through which TWIST2 controls enhancer H3K27ac to sustain oncogenic growth and block myogenesis in FN-RMS.\",\n      \"evidence\": \"Reciprocal co-IP, H3K27ac ChIP-seq, RNA-seq, shRNA knockdown, mouse xenograft\",\n      \"pmids\": [\"37115930\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How TWIST2 selects activating vs repressive enhancers not resolved\", \"Stoichiometry of the TWIST2-SMARCA4-CHD3 assembly unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined TWIST2 as a negative regulator of adipocyte differentiation through temporal chromatin/transcription remodeling, with KO mice showing reduced lipid storage; and reaffirmed direct ADD1/SREBP1c competition at a shared E-box (CHRDL1).\",\n      \"evidence\": \"ATAC-seq/PRO-seq network analysis and KO mice (adipocyte); EMSA competition and reporter assays with WT vs Q119X (CHRDL1)\",\n      \"pmids\": [\"36810156\", \"37761873\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct adipogenic target genes not pinpointed\", \"Single-lab biochemistry for CHRDL1 competition\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extended TWIST2 repression to mitochondrial quality control and epithelial identity, repressing Bnip3 (renal injury/mitophagy) and being repressed by HOXA10 to restrain EMT in endometrium.\",\n      \"evidence\": \"RNAi in mice/HK-2 cells with promoter binding and mitophagy assays; CUT&RUN, transcriptomics, siRNA, and mouse implantation model\",\n      \"pmids\": [\"39918659\", \"41213962\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ChIP-grade binding mapping limited\", \"Single-lab studies for each axis\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How TWIST2 toggles between transcriptional repression and activation at different loci and cell contexts — including the structural determinants of cofactor (HDAC, SMARCA4/CHD3, Runx3) selection and the rules governing locus-specific chromatin opening vs closing — remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of TWIST2-cofactor complexes\", \"Determinants of activator vs repressor switching not defined\", \"Integration of post-translational control (SUMOylation) with genomic targeting unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 16, 22]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 4, 6, 10]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [2, 18, 31]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [6, 18]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [16, 22]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 16]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [16, 21, 22]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [5, 14, 24, 34]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3, 8, 18, 19]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [4, 10]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"E12\", \"MyoD\", \"MEF2\", \"ADD1/SREBP1c\", \"PDCD4\", \"Runx3\", \"SMARCA4\", \"CHD3\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}